• Mercedes' new all-electric concept car shows just how serious the company is about taking on Tesla

    4 days ago - By Chron

    Michael Probst/AP
    Mercedes-Benz is going all in on electric cars.
    On Monday, Daimler, the automaker's parent company, said that Mercedes will sell electrified versions of all of its models by 2022. And on Tuesday, the company showcased an all-electric concept car, dubbed the Mercedes Concept EQA, that hints at what its future electric compact cars might look like.
    While the company didn't say whether the EQA would go into production, the company did make clear that the compact segment was important to it.
    "The Mercedes-Benz Concept EQA proves that we are serious about introducing electric...
    Read more ...

     

  • 23andMe is getting serious about drug development - and it could signal a fresh approach to finding new medicines

    4 days ago - By Chron

    Brad Barket/Getty
    23andMe, a company known for its consumer genetics test, is also looking to develop new drugs.
    The company raised $250 million on Tuesday, and the funding will in part go toward drug development.
    While drug development and consumer genetics tests might seem like vastly different businesses, the link could be critical to finding new treatments for diseases.
    23andMe is getting serious about drug development.
    On Tuesday, 23andMe announced that it had raised $250 million valuing the company at a reported $1.5 billion, and said that that funding will in part go toward...
    Read more ...

     

  • 23andMe is getting serious about drug development - and it could signal a fresh approach to finding new medicines

    23andMe is getting serious about drug development - and it could signal a fresh approach to finding new medicines

    4 days ago - By Business Insider

    23andMe, a company known for its consumer genetics test, is also looking to develop new drugs.
    The company raised $250 million on Tuesday, and the funding will in part go toward drug development.
    While drug development and consumer genetics tests might seem like vastly different businesses, the link could be critical to finding new treatments for diseases.
    23andMe is getting serious about drug development.
    On Tuesday, 23andMe announced that it had raised $250 million valuing the company at a reported $1.5 billion , and said that that funding will in part go toward developing 23andMe-made...
    Read more ...

     

  • Mercedes' new all-electric concept car shows just how serious the company is about taking on Tesla

    Mercedes' new all-electric concept car shows just how serious the company is about taking on Tesla

    4 days ago - By Business Insider

    Mercedes-Benz is going all in on electric cars.
    On Monday, Daimler, the automaker's parent company, said that Mercedes will sell electrified versions of all of its models by 2022 . And on Tuesday, the company showcased an all-electric concept car, dubbed the Mercedes Concept EQA, that hints at what its future electric compact cars might look like.
    While the company didn't say whether the EQA would go into production, the company did make clear that the compact segment was important to it.
    "The Mercedes-Benz Concept EQA proves that we are serious about introducing electric mobility...
    Read more ...

     

  • 23andMe is getting serious about drug development - and it could signal a fresh approach to finding new medicines

    23andMe is getting serious about drug development - and it could signal a fresh approach to finding new medicines

    4 days ago - By Business Insider

    23andMe, a company known for its consumer genetics test, is also looking to develop new drugs.
    The company raised $250 million on Tuesday, and the funding will in part go toward drug development.
    While drug development and consumer genetics tests might seem like vastly different businesses, the link could be critical to finding new treatments for diseases.
    23andMe is getting serious about drug development.
    On Tuesday, 23andMe announced that it had raised $250 million valuing the company at a reported $1.5 billion , and said that that funding will in part go toward developing 23andMe-made...
    Read more ...